Back to search

Article

Loss of CD109 Amplifies NF-κB Signaling and Inflammatory Reprogramming in Dermal Fibroblasts

2026-07-06

Abstract excerpt

Fibroproliferative diseases such as systemic sclerosis are complex conditions characterized by chronic skin inflammation and progressive fibrosis, with fibroblast activation as a central feature. While Transforming Growth Factor Beta (TGF-β) signaling is a well-established driver of fibrosis in SSc, inflammatory pathways such as Nuclear Factor Kappa B (NF-κB) also contribute substantially to disease morbidity. We...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0fe236ed-f477-5161-b258-52920cf383d4
DOI
10.64898/2026.07.03.736423
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Loss of CD109 Amplifies NF-κB Signaling and Inflammatory Reprogramming in Dermal FibroblastsDOI 10.64898/2026.07.03.736423
Select a neighboring publication to make it the new centre.